概括
患有α-1-抗素缺乏症的肺气患者的肝细胞积累了异常的葡萄糖蛋白球体. 这表明,尽管血清缺乏,但分子问题阻止了肝细胞正确释放α-1-抗素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔法-1-抗素缺乏症是一种遗传性疾病,通常导致肺气.
- 患有这种缺乏症的患者表现出低血清水平的α-1-抗素.
- 肝脏在α-1-抗素生产和潜在功能障碍中的作用尚未完全理解.
研究的目的:
- 为了调查alpha-1-antitrypsin在肝细胞中的存在和特征,患有肺气和遗传alpha-1-antitrypsin缺乏症的患者.
- 探索阿尔法-1-抗素在肝细胞内积累的潜在原因.
主要方法:
- 从肺瘤患者的肝脏活检的组织学检查.
- 免疫光染色以检测α-1-抗素.
- 定期的酸-Schiff (PAS) 染色与粉酶处理相结合.
- 电子显微镜. 电子显微镜.
主要成果:
- 帕伦基马性肝细胞含有糖蛋白球体,它们与对抗α-1-抗素的抗体结合.
- 这些球体可以通过标准染色 (血素和素) 和电子显微镜观察到.
- 粉酶处理部分的PAS染色更容易显示这些球体.
- 在肝细胞中发现高水平的α-1-抗素,与低血清水平形成鲜明对比.
结论:
- 患有α-1-抗素缺乏症和肺的个体的肝细胞积累了异常的α-1-抗素沉积物.
- 一个分子缺陷或异常在阿尔法-1抗素的遗传变体可能会损害其从肝细胞分泌.
- 这种细胞内保留有助于肝脏病理和全身缺陷.
相关概念视频
01:05Breathing
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...